All terms in SNOMED
| Label | Id | Description |
|---|---|---|
| Group J (qualifier value) | 261594006 | |
| Passive range of toe abduction (observable entity) | 299611002 | |
| Product containing only avapritinib (medicinal product) | 838471001 | |
| Product containing avapritinib (medicinal product) | 838409003 | |
| Onychomatricoma (disorder) | 773629001 | [A rare benign nail tumour originating in the nail matrix characterised by localised or diffuse thickening of the nail plate, increased transverse or longitudinal overcurvature, a yellow longitudinal band of variable width, swelling of the proximal nail fold, multiple splinter haemorrhages and the presence of honeycomb-like cavities in the distal margin of the nail plate. Nail dystrophy and dorsal pterygium may be associated. Occasionally a pigmented lesion has been reported., A rare benign nail tumor originating in the nail matrix characterized by localized or diffuse thickening of the nail plate, increased transverse or longitudinal overcurvature, a yellow longitudinal band of variable width, swelling of the proximal nail fold, multiple splinter hemorrhages and the presence of honeycomb-like cavities in the distal margin of the nail plate. Nail dystrophy and dorsal pterygium may be associated. Occasionally a pigmented lesion has been reported.] |
| Decreased vitamin A and/or vitamin A derivative diet (regime/therapy) | 1141933008 | [Decrease in vitamin A content of the diet compared to the assessed baseline intake of vitamin A for the individual.] |
| Entire middle articular surface for talus (body structure) | 182113004 | |
| Structure of middle articular surface for talus (body structure) | 45840008 | |
| Product containing precisely amantadine hydrochloride 100 milligram/1 each conventional release oral tablet (clinical drug) | 375373003 | |
| Lactose tolerance (finding) | 251399004 | |
| Vaccine product containing only Neisseria meningitidis serogroup B antigen (medicinal product) | 1981000221108 | |
| Subfamily Trichostrongylinae (organism) | 424781005 | |
| Temozolomide (substance) | 387009002 | |
| Home seizure monitoring system (physical object) | 711608002 | |
| Congenital pulmonary alveolar proteinosis (disorder) | 707442002 | |
| Faenia rectivirgula antibody level (procedure) | 315120008 | |
| Congenital ovarian dysplasia (disorder) | 360426005 | |
| Entire lymphatic vessel of nasal cavity (body structure) | 368897002 | |
| Structure of lymphatic vessel of nasal cavity (body structure) | 70360003 | |
| Entire costotransverse foramen (body structure) | 727253000 |